{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:56:24Z","timestamp":1792756584612,"version":"4.5.0"},"reference-count":213,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG048030"],"award-info":[{"award-number":["AG048030"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG048017"],"award-info":[{"award-number":["AG048017"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG047655"],"award-info":[{"award-number":["AG047655"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG055421"],"award-info":[{"award-number":["AG055421"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG055682"],"award-info":[{"award-number":["AG055682"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1F31AG057150"],"award-info":[{"award-number":["1F31AG057150"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13024-019-0324-6","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T07:03:02Z","timestamp":1560236582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":173,"title":["Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Ramsey","family":"Najm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-4589","authenticated-orcid":false,"given":"Yadong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"324_CR1","unstructured":"Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M. World Alzheimer Report 2015: The Global Impact of Dementia. Alzheimer\u2019s Disease International. 2015."},{"issue":"4","key":"324_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","volume":"6","author":"DJ Selkoe","year":"1991","unstructured":"Selkoe DJ. The molecular pathology of Alzheimer\u2019s disease. Neuron. 1991;6(4):487\u201398.","journal-title":"Neuron."},{"issue":"4","key":"324_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer\u2019s disease. N Engl J Med. 2010;362(4):329\u201344.","journal-title":"N Engl J Med"},{"issue":"6","key":"324_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;148(6):1204\u201322.","journal-title":"Cell."},{"issue":"3","key":"324_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron. 2009;63(3):287\u2013303.","journal-title":"Neuron."},{"issue":"2","key":"324_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"324_CR7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu H, Bu G. ApoE and A\u03b2 in Alzheimer\u2019s disease: accidental encounters or partners? Neuron. 2014;81(4):740\u201354.","journal-title":"Neuron."},{"key":"324_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","volume":"72","author":"Y Huang","year":"2014","unstructured":"Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol Dis. 2014;72:3\u201312.","journal-title":"Neurobiol Dis"},{"key":"324_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","volume":"47","author":"AD Roses","year":"1996","unstructured":"Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease. Annu Rev Med. 1996;47:387\u2013400.","journal-title":"Annu Rev Med"},{"issue":"5123","key":"324_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science."},{"issue":"16","key":"324_CR11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA J Am Med Assoc. 1997;278(16):1349\u201356.","journal-title":"JAMA J Am Med Assoc"},{"issue":"5","key":"324_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G. Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009;10(5):333\u201344.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"324_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","volume":"94","author":"RW Mahley","year":"2016","unstructured":"Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med. 2016;94(7):739\u201346.","journal-title":"J Mol Med"},{"issue":"15","key":"324_CR14","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2006;103(15):5644\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"324_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","volume":"31","author":"DM Hatters","year":"2006","unstructured":"Hatters DM, Peters-Libeu CA, Weisgraber KH. Apolipoprotein E structure: insights into function. Trends Biochem Sci. 2006;31(8):445\u201354.","journal-title":"Trends Biochem Sci"},{"issue":"28","key":"324_CR16","doi-asserted-by":"publisher","first-page":"E1972","DOI":"10.1073\/pnas.1208003109","volume":"109","author":"C Frieden","year":"2012","unstructured":"Frieden C, Garai K. Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer\u2019s disease. Proc Natl Acad Sci. 2012;109(28):E1972\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"36","key":"324_CR17","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1073\/pnas.1106420108","volume":"108","author":"J Chen","year":"2011","unstructured":"Chen J, Li Q, Wang J. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci. 2011;108(36):14813\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"40","key":"324_CR18","doi-asserted-by":"publisher","first-page":"34288","DOI":"10.1074\/jbc.M506044200","volume":"280","author":"DM Hatters","year":"2005","unstructured":"Hatters DM, Budamagunta MS, Voss JC, Weisgraber KH. Modulation of apolipoprotein E structure by domain interaction: differences in lipid-bound and lipid-free forms. J Biol Chem. 2005;280(40):34288\u201395.","journal-title":"J Biol Chem"},{"issue":"24","key":"324_CR19","doi-asserted-by":"publisher","first-page":"25511","DOI":"10.1074\/jbc.M311256200","volume":"279","author":"Q Xu","year":"2004","unstructured":"Xu Q, Brecht WJ, Weisgraber KH, Mahley RW, Huang Y. Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J Biol Chem. 2004;279(24):25511\u20136.","journal-title":"J Biol Chem"},{"issue":"10","key":"324_CR20","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht WJ, Harris FM, Chang S, Tesseur I, Yu G-Q, Xu Q, et al. Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci. 2004;24(10):2527\u201334.","journal-title":"J Neurosci"},{"issue":"6","key":"324_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.molmed.2010.04.004","volume":"16","author":"Y Huang","year":"2010","unstructured":"Huang Y. A\u03b2-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer\u2019s disease. Trends Mol Med. 2010;16(6):287\u201394.","journal-title":"Trends Mol Med"},{"issue":"5","key":"324_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","volume":"76","author":"RW Mahley","year":"2012","unstructured":"Mahley RW, Huang Y. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron. 2012;76(5):871\u201385.","journal-title":"Neuron."},{"issue":"3","key":"324_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1523\/JNEUROSCI.21-03-00812.2001","volume":"21","author":"S Grehan","year":"2001","unstructured":"Grehan S, Tse E, Taylor JM. Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. J Neurosci. 2001;21(3):812\u201322.","journal-title":"J Neurosci"},{"issue":"1","key":"324_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","volume":"917","author":"RE Pitas","year":"1987","unstructured":"Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta (BBA)\/Lipids Lipid Metab. 1987;917(1):148\u201361.","journal-title":"Biochim Biophys Acta (BBA)\/Lipids Lipid Metab"},{"issue":"19","key":"324_CR25","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 2006;26(19):4985\u201394.","journal-title":"J Neurosci"},{"issue":"3","key":"324_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/nbdi.1996.0023","volume":"3","author":"PT Xu","year":"1996","unstructured":"Xu PT, Schmechel D, Rothrock-Christian T, Burkhart DS, Qiu HL, Popko B, et al. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol Dis. 1996;3(3):229\u201345.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"324_CR27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","volume":"18","author":"Yang Shi","year":"2018","unstructured":"Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol. 2018. https:\/\/doi.org\/10.1038\/s41577-018-0051-1 .","journal-title":"Nature Reviews Immunology"},{"issue":"3","key":"324_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/JMN:23:3:189","volume":"23","author":"Y Huang","year":"2004","unstructured":"Huang Y, Weisgraber KH, Mucke L, Mahley RW. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer\u2019s disease. J Mol Neurosci. 2004;23(3):189\u2013204.","journal-title":"J Mol Neurosci"},{"issue":"26","key":"324_CR29","doi-asserted-by":"publisher","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","volume":"96","author":"KR Bales","year":"1999","unstructured":"Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci. 1999;96(26):15233\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"324_CR30","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2000;97(6):2892\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"324_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-\u03b2 peptides. Nat Med. 2004;10(7):719\u201326.","journal-title":"Nat Med"},{"issue":"89","key":"324_CR32","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, Demattos RB, Patterson BW, et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. 2011;3(89):89ra57.","journal-title":"Sci Transl Med"},{"issue":"18","key":"324_CR33","doi-asserted-by":"publisher","first-page":"10602","DOI":"10.1074\/jbc.271.18.10602","volume":"271","author":"AA Golabek","year":"1996","unstructured":"Golabek AA, Soto C, Vogel T, Wisniewski T. The interaction between apolipoprotein E and Alzheimer\u2019s amyloid \u03b2-peptide is dependent on \u03b2-peptide conformation. J Biol Chem. 1996;271(18):10602\u20136.","journal-title":"J Biol Chem"},{"issue":"5","key":"324_CR34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jmb.2006.06.080","volume":"361","author":"DM Hatters","year":"2006","unstructured":"Hatters DM, Zhong N, Rutenber E, Weisgraber KH. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils. J Mol Biol. 2006;361(5):932\u201344.","journal-title":"J Mol Biol"},{"issue":"21","key":"324_CR35","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","volume":"29","author":"KR Bales","year":"2009","unstructured":"Bales KR, Liu F, Wu S, Lin S, Koger D, DeLong C, et al. Human APOE isoform-dependent effects on brain \u03b2-amyloid levels in PDAPP transgenic mice. J Neurosci. 2009;29(21):6771\u20139.","journal-title":"J Neurosci"},{"issue":"40","key":"324_CR36","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"50","key":"324_CR37","doi-asserted-by":"publisher","first-page":"41774","DOI":"10.1074\/jbc.M112.407957","volume":"287","author":"KL Youmans","year":"2012","unstructured":"Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, et al. APOE4-specific changes in A\u03b2 accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem. 2012;287(50):41774\u201386.","journal-title":"J Biol Chem"},{"issue":"8","key":"324_CR38","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1074\/jbc.M116.755264","volume":"292","author":"A Hatami","year":"2017","unstructured":"Hatami A, Monjazeb S, Milton S, Glabe CG. Familial Alzheimer\u2019s disease mutations within the amyloid precursor protein Alter the aggregation and conformation of the amyloid-\u03b2 peptide. J Biol Chem. 2017;292(8):3172\u201385.","journal-title":"J Biol Chem"},{"issue":"14","key":"324_CR39","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1523\/JNEUROSCI.0033-12.2012","volume":"32","author":"N Bien-Ly","year":"2012","unstructured":"Bien-Ly N, Gillespie AK, Walker D, Yoon SY, Huang Y. Reducing human apolipoprotein E levels attenuates age-dependent A\u03b2 accumulation in mutant human amyloid precursor protein transgenic mice. J Neurosci. 2012;32(14):4803\u201311.","journal-title":"J Neurosci"},{"issue":"49","key":"324_CR40","doi-asserted-by":"publisher","first-page":"18007","DOI":"10.1523\/JNEUROSCI.3773-11.2011","volume":"31","author":"J Kim","year":"2011","unstructured":"Kim J, Jiang H, Park S, Eltorai AEM, Stewart FR, Yoon H, et al. Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-\u03b2 amyloidosis. J Neurosci. 2011;31(49):18007\u201312.","journal-title":"J Neurosci"},{"key":"324_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1749-6632.2000.tb06919.x","volume":"920","author":"MC Irizarry","year":"2000","unstructured":"Irizarry MC, Rebeck GW, Cheung B, Bales K, Paul SM, Holzman D, et al. Modulation of A\u03b2 deposition in APP transgenic mice by an apolipoprotein E null background. Ann N Y Acad Sci. 2000;920:171\u20138.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"324_CR42","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1172\/JCI6179","volume":"103","author":"DM Holtzman","year":"1999","unstructured":"Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, et al. Expression of human apolipoprotein E reduces amyloid-\u03b2 deposition in a mouse model of Alzheimer\u2019s disease. J Clin Invest. 1999;103(6):R15\u201321.","journal-title":"J Clin Invest"},{"issue":"11","key":"324_CR43","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","volume":"25","author":"JD Fryer","year":"2005","unstructured":"Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, et al. Human apolipoprotein E4 alters the amyloid-\u03b2 40:42 ratio and promotes the formation of cerebral amyloid Angiopathy in an amyloid precursor protein transgenic model. J Neurosci. 2005;25(11):2803\u201310.","journal-title":"J Neurosci"},{"key":"324_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","volume":"66","author":"JD Harper","year":"1997","unstructured":"Harper JD, Lansbury PT. Models of amyloid seeding in Alzheimer\u2019s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem. 1997;66:385\u2013407.","journal-title":"Annu Rev Biochem"},{"issue":"11","key":"324_CR45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S1074-5521(96)90183-0","volume":"3","author":"SJ Wood","year":"1996","unstructured":"Wood SJ, Chan W, Wetzel R. An ApoE-A\u03b2 inhibition complex in A\u03b2 fibril extension. Chem Biol. 1996;3(11):949\u201356.","journal-title":"Chem Biol"},{"issue":"43","key":"324_CR46","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, et al. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide. J Neurosci. 2012;32(43):15181\u201392.","journal-title":"J Neurosci"},{"issue":"5","key":"324_CR47","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1096\/fj.10-175976","volume":"25","author":"E Cerf","year":"2011","unstructured":"Cerf E, Gustot A, Goormaghtigh E, Ruysschaert J-M, Raussens V. High ability of apolipoprotein E4 to stabilize amyloid-\u03b2 peptide oligomers, the pathological entities responsible for Alzheimer\u2019s disease. FASEB J. 2011;25(5):1585\u201395.","journal-title":"FASEB J"},{"issue":"20","key":"324_CR48","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1021\/bi9624705","volume":"36","author":"H Naiki","year":"1997","unstructured":"Naiki H, Gejyo F, Nakakuki K. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer\u2019s \u03b2-amyloid fibril formation in vitro. Biochemistry. 1997;36(20):6243\u201350.","journal-title":"Biochemistry."},{"issue":"6075","key":"324_CR49","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE, Cirrito JR, Wesson DW, Lee CYD, Karlo JC, Zinn AE, et al. ApoE-directed therapeutics rapidly clear \u03b2 -amyloid and reverse deficits in AD mouse models. Science. 2012;335(6075):1503\u20136.","journal-title":"Science."},{"issue":"4","key":"324_CR50","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.mcn.2007.01.011","volume":"34","author":"DR Riddell","year":"2007","unstructured":"Riddell DR, Zhou H, Comery TA, Kouranova E, Lo CF, Warwick HK, et al. The LXR agonist TO901317 selectively lowers hippocampal A\u03b242 and improves memory in the Tg2576 mouse model of Alzheimer\u2019s disease. Mol Cell Neurosci. 2007;34(4):621\u20138.","journal-title":"Mol Cell Neurosci"},{"issue":"19","key":"324_CR51","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1523\/JNEUROSCI.6546-10.2011","volume":"31","author":"D Terwel","year":"2011","unstructured":"Terwel D, Steffensen KR, Verghese PB, Kummer MP, Gustafsson J-A, Holtzman DM, et al. Critical role of Astroglial apolipoprotein E and liver X receptor-alpha expression for microglial A\u03b2 phagocytosis. J Neurosci. 2011;31(19):7049\u201359.","journal-title":"J Neurosci"},{"issue":"12","key":"324_CR52","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1084\/jem.20121274","volume":"209","author":"J Kim","year":"2012","unstructured":"Kim J, Eltorai AEM, Jiang H, Liao F, Verghese PB, Kim J, et al. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of A\u03b2 amyloidosis. J Exp Med. 2012;209(12):2149\u201356.","journal-title":"J Exp Med"},{"issue":"2","key":"324_CR53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1046\/j.0953-816x.2001.01643.x","volume":"14","author":"B Vincent","year":"2001","unstructured":"Vincent B, Smith JD. Astrocytes down-regulate neuronal \u03b2-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner. Eur J Neurosci. 2001;14(2):256\u201366.","journal-title":"Eur J Neurosci"},{"issue":"5","key":"324_CR54","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"C-C Liu","year":"2017","unstructured":"Liu C-C, Zhao N, Fu Y, Wang N, Linares C, Tsai C-W, et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron. 2017;96(5):1024\u20131032.e3.","journal-title":"Neuron."},{"issue":"5","key":"324_CR55","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"T-PV Huynh","year":"2017","unstructured":"Huynh T-PV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H, et al. Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron. 2017;96(5):1013\u201323.","journal-title":"Neuron."},{"issue":"5","key":"324_CR56","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1471-4159.2004.02581.x","volume":"90","author":"MC Irizarry","year":"2004","unstructured":"Irizarry MC, Deng A, Lleo A, Berezovska O, von Arnim CAF, Martin-Rehrmann M, et al. Apolipoprotein E modulates \u03b3-secretase cleavage of the amyloid precursor protein. J Neurochem. 2004;90(5):1132\u201343.","journal-title":"J Neurochem"},{"issue":"12","key":"324_CR57","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al. apoE isoform \u2013 specific disruption of amyloid \u03b2 peptide clearance from mouse brain. J Clin Invest. 2008;118(12):4002\u201313.","journal-title":"J Clin Invest"},{"issue":"15","key":"324_CR58","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","volume":"37","author":"C-C Liu","year":"2017","unstructured":"Liu C-C, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, et al. Astrocytic LRP1 mediates brain A\u03b2 clearance and impacts amyloid deposition. J Neurosci. 2017;37(15):4023\u201331.","journal-title":"J Neurosci"},{"issue":"1","key":"324_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","volume":"13","author":"Q Ma","year":"2018","unstructured":"Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, et al. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener. 2018;13(1):57.","journal-title":"Mol Neurodegener"},{"issue":"28","key":"324_CR60","doi-asserted-by":"publisher","first-page":"E6640","DOI":"10.1073\/pnas.1801612115","volume":"115","author":"H Prasad","year":"2018","unstructured":"Prasad H, Rao R. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH. Proc Natl Acad Sci. 2018;115(28):E6640\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"324_CR61","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1073\/pnas.1018381108","volume":"108","author":"N Bien-Ly","year":"2011","unstructured":"Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Wang C, Huang Y. C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-\u03b2(A\u03b2) and acts in concert with A\u03b2 to elicit neuronal and behavioral deficits in mice. Proc Natl Acad Sci U S A. 2011;108(10):4236\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"324_CR62","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/ATVBAHA.111.222745","volume":"31","author":"D Baitsch","year":"2011","unstructured":"Baitsch D, Bock HH, Engel T, Telgmann R, M\u00fcller-Tidow C, Varga G, et al. Apolipoprotein E induces Antiinflammatory phenotype in macrophages. Arterioscler Thromb Vasc Biol. 2011;31(5):1160\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"324_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Nwabuisi-Heath E, Dumanis SB, Tai LM, Yu C, Rebeck GW, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 2012;60(4):559\u201369.","journal-title":"Glia."},{"issue":"6","key":"324_CR64","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1096\/fj.10-176891","volume":"25","author":"E Cudaback","year":"2011","unstructured":"Cudaback E, Li X, Montine KS, Montine TJ, Keene CD. Apolipoprotein E isoform-dependent microglia migration. FASEB J. 2011;25(6):2082\u201391.","journal-title":"FASEB J"},{"key":"324_CR65","doi-asserted-by":"crossref","unstructured":"Fernandez CG, Hamby ME, McReynolds ML, Ray WJ. The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer's Disease. Front Aging Neurosci. 2019. https:\/\/doi.org\/10.3389\/fnagi.2019.00014 .","DOI":"10.3389\/fnagi.2019.00014"},{"issue":"49","key":"324_CR66","doi-asserted-by":"publisher","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","volume":"33","author":"T Kanekiyo","year":"2013","unstructured":"Kanekiyo T, Cirrito JR, Liu C-C, Shinohara M, Li J, Schuler DR, et al. Neuronal clearance of amyloid-\u03b2 by endocytic receptor LRP1. J Neurosci. 2013;33(49):19276\u201383.","journal-title":"J Neurosci"},{"issue":"9","key":"324_CR67","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, Herrmann FR, Bussi\u00e8re T, Bouras C, K\u00f6vari E, Perl DP, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology. 2003;60(9):1495\u2013500.","journal-title":"Neurology."},{"issue":"18","key":"324_CR68","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1073\/pnas.95.18.10914","volume":"95","author":"J Raber","year":"1998","unstructured":"Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A. 1998;95(18):10914\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6776","key":"324_CR69","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/35006165","volume":"404","author":"J Raber","year":"2000","unstructured":"Raber J, Wong D, Yu G-Q, Buttini M, Mahley R, Pitas R, et al. Apolipoprotein E and cognitive performance. Nature. 2000;404(6776):352\u20134.","journal-title":"Nature."},{"issue":"12","key":"324_CR70","doi-asserted-by":"publisher","first-page":"e53569","DOI":"10.1371\/journal.pone.0053569","volume":"7","author":"L Leung","year":"2012","unstructured":"Leung L, Andrews-Zwilling Y, Yoon SY, Jain S, Ring K, Dai J, et al. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice. PLoS One. 2012;7(12):e53569.","journal-title":"PLoS One"},{"issue":"41","key":"324_CR71","doi-asserted-by":"publisher","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling Y, Bien-Ly N, Xu Q, Li G, Bernardo A, Yoon SY, et al. Apolipoprotein E4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci. 2010;30(41):13707\u201317.","journal-title":"J Neurosci"},{"issue":"19","key":"324_CR72","doi-asserted-by":"publisher","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","volume":"286","author":"J Brodbeck","year":"2011","unstructured":"Brodbeck J, McGuire J, Liu Z, Meyer-Franke A, Balestra ME, Jeong DE, et al. Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by Small-molecule structure correctors. J Biol Chem. 2011;286(19):17217\u201326.","journal-title":"J Biol Chem"},{"issue":"48","key":"324_CR73","doi-asserted-by":"publisher","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","volume":"29","author":"SB Dumanis","year":"2009","unstructured":"Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, Ladu MJ, et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci. 2009;29(48):15317\u201322.","journal-title":"J Neurosci"},{"issue":"6","key":"324_CR74","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","volume":"5","author":"G Li","year":"2009","unstructured":"Li G, Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Ring K, et al. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 Knockin mice. Cell Stem Cell. 2009;5(6):634\u201345.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"324_CR75","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1474-4422(07)70106-0","volume":"6","author":"P Shaw","year":"2007","unstructured":"Shaw P, Lerch JP, Pruessner JC, Taylor KN, Rose AB, Greenstein D, et al. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol. 2007;6(6):494\u2013500.","journal-title":"Lancet Neurol"},{"issue":"11","key":"324_CR76","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"324_CR77","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","volume":"56","author":"Md. Sahab Uddin","year":"2018","unstructured":"Uddin MS, Kabir MT, Al Mamun A, Abdel-Daim MM, Barreto GE, Ashraf GM. APOE and Alzheimer\u2019s disease: evidence mounts that targeting APOE4 may combat Alzheimer\u2019s pathogenesis. Mol Neurobiol. 2018. https:\/\/doi.org\/10.1007\/s12035-018-1237-z .","journal-title":"Molecular Neurobiology"},{"issue":"15","key":"324_CR78","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1073\/pnas.151254698","volume":"98","author":"Y Huang","year":"2001","unstructured":"Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW. Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci. 2001;98(15):8838\u201343.","journal-title":"Proc Natl Acad Sci"},{"key":"324_CR79","doi-asserted-by":"publisher","first-page":"10966","DOI":"10.1073\/pnas.1434398100","volume":"100","author":"FM Harris","year":"2003","unstructured":"Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, Wyss-Coray T, et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer\u2019s disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A. 2003;100:10966\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7673","key":"324_CR80","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549(7673):523\u20137.","journal-title":"Nature."},{"issue":"1","key":"324_CR81","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","volume":"9","author":"N Zhao","year":"2018","unstructured":"Zhao N, Liu C-C, Van Ingelgom AJ, Linares C, Kurti A, Knight JA, et al. APOE \u03b52 is associated with increased tau pathology in primary tauopathy. Nat Commun. 2018;9(1):4388.","journal-title":"Nat Commun"},{"issue":"10","key":"324_CR82","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","volume":"21","author":"H Fu","year":"2018","unstructured":"Fu H, Hardy J, Duff KE. Selective vulnerability in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1350\u20138.","journal-title":"Nat Neurosci"},{"issue":"8","key":"324_CR83","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.molmed.2011.03.003","volume":"17","author":"K Ramamoorthi","year":"2011","unstructured":"Ramamoorthi K, Lin Y. The contribution of GABAergic dysfunction to neurodevelopmental disorders. Trends Mol Med. 2011;17(8):452\u201362.","journal-title":"Trends Mol Med"},{"issue":"8","key":"324_CR84","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/ijms18081813","volume":"18","author":"K Govindpani","year":"2017","unstructured":"Govindpani K, Calvo-Flores Guzm\u00e1n B, Vinnakota C, Waldvogel H, Faull R, Kwakowsky A, et al. Towards a better understanding of GABAergic remodeling in Alzheimer\u2019s disease. Int J Mol Sci. 2017;18(8):1813.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"324_CR85","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/070674370404900705","volume":"49","author":"KL Lanct\u00f4t","year":"2016","unstructured":"Lanct\u00f4t KL, Herrmann N, Mazzotta P, Khan LR, Ingber N. GABAergic function in Alzheimer\u2019s disease: evidence for dysfunction and potential as a therapeutic target for the treatment of Behavioural and psychological symptoms of dementia. Can J Psychiatr. 2016;49(7):439\u201353.","journal-title":"Can J Psychiatr"},{"key":"324_CR86","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/neuro.05.028.2009","volume":"3","author":"V Garcia-Marin","year":"2009","unstructured":"Garcia-Marin V, Blazquez-Llorca L, Rodriguez J-R, Boluda S, Muntane G, Ferrer I, et al. Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques. Front Neuroanat. 2009;3:28.","journal-title":"Front Neuroanat"},{"key":"324_CR87","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-015-0061-4","volume":"10","author":"A Ramos-Miguel","year":"2015","unstructured":"Ramos-Miguel A, Hercher C, Beasley CL, Barr AM, Bayer TA, Falkai P, et al. Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener. 2015;10:65.","journal-title":"Mol Neurodegener"},{"issue":"10","key":"324_CR88","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/BF01367587","volume":"23","author":"A Soricelli","year":"1996","unstructured":"Soricelli A, Postiglione A, Grivet-Fojaja MR, Mainenti PP, Discepolo A, Varrone A, et al. Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer\u2019s disease as a measure of loss of synapses. Eur J Nucl Med. 1996;23(10):1323\u20138.","journal-title":"Eur J Nucl Med"},{"issue":"3","key":"324_CR89","first-page":"467","volume":"38","author":"K Fukuchi","year":"1997","unstructured":"Fukuchi K, Hashikawa K, Seike Y, Moriwaki H, Oku N, Ishida M, et al. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer\u2019s disease. J Nucl Med. 1997;38(3):467\u201370.","journal-title":"J Nucl Med"},{"issue":"11","key":"324_CR90","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/archneur.1982.00510230035010","volume":"39","author":"SR Bareggi","year":"1982","unstructured":"Bareggi SR, Franceschi M, Bonini L, Zecca L, Smirne S. Decreased CSF concentrations of Homovanillic acid and \u03b3-aminobutyric acid in Alzheimer\u2019s disease. Age- or disease-related modifications? Arch Neurol. 1982;39(11):709.","journal-title":"Arch Neurol"},{"issue":"6","key":"324_CR91","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/archneur.1984.04210080010005","volume":"41","author":"R Zimmer","year":"1984","unstructured":"Zimmer R, Teelken AW, Trieling WB, Weber W, Weihmayr T, Lauter H. \u03b3-aminobutyric acid and Homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer\u2019s type. Arch Neurol. 1984;41(6):602\u20134.","journal-title":"Arch Neurol"},{"issue":"6","key":"324_CR92","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/archneur.1980.00500550054006","volume":"37","author":"NV Manyam","year":"1980","unstructured":"Manyam NV, Katz L, Hare TA, Gerber JC, Grossman MH. Levels of \u03b3-aminobutyric acid in cerebrospinal fluid in various neurologic disorders. Arch Neurol. 1980;37(6):352\u20135.","journal-title":"Arch Neurol"},{"issue":"11","key":"324_CR93","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/archneur.1977.00500230053008","volume":"34","author":"SJ Enna","year":"1977","unstructured":"Enna SJ, Stern LZ, Wastek GJ, Yamamura HI. Cerebrospinal fluid \u03b3-aminobutyric acid variations in neurological disorders. Arch Neurol. 1977;34(11):683\u20135.","journal-title":"Arch Neurol"},{"issue":"5788","key":"324_CR94","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/288279a0","volume":"288","author":"P Davies","year":"1980","unstructured":"Davies P, Katzman R, Terry RD. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 1980;288(5788):279\u201380.","journal-title":"Nature."},{"issue":"2","key":"324_CR95","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/cne.902600205","volume":"260","author":"V Chan-Palay","year":"1987","unstructured":"Chan-Palay V. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold\/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia. J Comp Neurol. 1987;260(2):201\u201323.","journal-title":"J Comp Neurol"},{"issue":"10","key":"324_CR96","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1096\/fasebj.4.10.2165009","volume":"4","author":"AM Palmer","year":"1990","unstructured":"Palmer AM, Gershon S. Is the neuronal basis of Alzheimer\u2019s disease cholinergic or glutamatergic ? Faseb. 1990;4(10):2745\u201352.","journal-title":"Faseb."},{"issue":"SUPPL. 3","key":"324_CR97","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x","volume":"42","author":"DM Treiman","year":"2001","unstructured":"Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42(SUPPL. 3):8\u201312.","journal-title":"Epilepsia."},{"issue":"4","key":"324_CR98","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneurol.2009.15","volume":"66","author":"JJ Palop","year":"2009","unstructured":"Palop JJ, Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol. 2009;66(4):435\u201340.","journal-title":"Arch Neurol"},{"issue":"7","key":"324_CR99","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop JJ, Mucke L. Amyloid-\u03b2-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci. 2010;13(7):812\u20138.","journal-title":"Nat Neurosci"},{"issue":"9","key":"324_CR100","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","volume":"70","author":"KA Vossel","year":"2013","unstructured":"Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013;70(9):1158\u201366.","journal-title":"JAMA Neurol"},{"issue":"5","key":"324_CR101","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron. 2007;55(5):697\u2013711.","journal-title":"Neuron."},{"issue":"4","key":"324_CR102","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3233\/JAD-170392","volume":"60","author":"JC DiFrancesco","year":"2017","unstructured":"DiFrancesco JC, Tremolizzo L, Polonia V, Giussani G, Bianchi E, Franchi C, et al. Adult-onset epilepsy in Presymptomatic Alzheimer\u2019s disease: a retrospective study. J Alzheimers Dis. 2017;60(4):1267\u201374.","journal-title":"J Alzheimers Dis"},{"issue":"42","key":"324_CR103","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci. 2012;109(42):E2895\u2013903.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"324_CR104","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/cns.12144","volume":"19","author":"J-Q Shi","year":"2013","unstructured":"Shi J-Q, Wang B-R, Tian Y-Y, Xu J, Gao L, Zhao S-L, et al. Antiepileptics Topiramate and Levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe\/PS1dE9 transgenic mice. CNS Neurosci Ther. 2013;19(11):871\u201381.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"324_CR105","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/npp.2009.207","volume":"35","author":"MT Koh","year":"2010","unstructured":"Koh MT, Haberman RP, Foti S, McCown TJ, Gallagher M. Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment. Neuropsychopharmacology. 2010;35(4):1016\u201325.","journal-title":"Neuropsychopharmacology."},{"key":"324_CR106","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.nlm.2013.02.001","volume":"102","author":"L Devi","year":"2013","unstructured":"Devi L, Ohno M. Effects of levetiracetam, an antiepileptic drug, on memory impairments associated with aging and Alzheimer\u2019s disease in mice. Neurobiol Learn Mem. 2013;102:7\u201311.","journal-title":"Neurobiol Learn Mem"},{"issue":"3","key":"324_CR107","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s13311-017-0541-z","volume":"14","author":"RP Haberman","year":"2017","unstructured":"Haberman RP, Branch A, Gallagher M. Targeting neural hyperactivity as a treatment to stem progression of late-onset Alzheimer\u2019s disease. Neurotherapeutics. 2017;14(3):662\u201376.","journal-title":"Neurotherapeutics."},{"issue":"9","key":"324_CR108","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/epi.13849","volume":"58","author":"MR Schoenberg","year":"2017","unstructured":"Schoenberg MR, Rum RS, Osborn KE, Werz MA. A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults. Epilepsia. 2017;58(9):1566\u201374.","journal-title":"Epilepsia."},{"issue":"3","key":"324_CR109","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","volume":"74","author":"A Bakker","year":"2012","unstructured":"Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74(3):467\u201374.","journal-title":"Neuron."},{"issue":"4","key":"324_CR110","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","volume":"17","author":"E Cumbo","year":"2010","unstructured":"Cumbo E, Ligori LD. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease. Epilepsy Behav. 2010;17(4):461\u20136.","journal-title":"Epilepsy Behav"},{"key":"324_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1993.tb23018.x","volume":"695","author":"R Moore","year":"1993","unstructured":"Moore R. Principles of synaptic transmission. Ann N Y Acad Sci. 1993;695:1\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"324_CR112","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/s41593-018-0226-x","volume":"21","author":"G Mongillo","year":"2018","unstructured":"Mongillo G, Rumpel S, Loewenstein Y. Inhibitory connectivity defines the realm of excitatory plasticity. Nat Neurosci. 2018;21(10):1463\u201370.","journal-title":"Nat Neurosci"},{"issue":"6552","key":"324_CR113","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/378075a0","volume":"378","author":"SR Cobb","year":"1995","unstructured":"Cobb SR, Buhl EH, Halasy K, Paulsen O, Somogyi P. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature. 1995;378(6552):75\u20138.","journal-title":"Nature."},{"issue":"Pt 1","key":"324_CR114","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1113\/jphysiol.2004.078915","volume":"562","author":"P Somogyi","year":"2005","unstructured":"Somogyi P, Klausberger T. Defined types of cortical interneurone structure space and spike timing in the hippocampus. J Physiol. 2005;562(Pt 1):9\u201326.","journal-title":"J Physiol"},{"issue":"10","key":"324_CR115","doi-asserted-by":"publisher","first-page":"e77796","DOI":"10.1371\/journal.pone.0077796","volume":"8","author":"X Xu","year":"2013","unstructured":"Xu X, An L, Mi X, Zhang T. Impairment of cognitive function and synaptic plasticity associated with alteration of information flow in Theta and gamma oscillations in melamine-treated rats. PLoS One. 2013;8(10):e77796.","journal-title":"PLoS One"},{"issue":"10","key":"324_CR116","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.tins.2018.07.015","volume":"41","author":"JA Cardin","year":"2018","unstructured":"Cardin JA. Inhibitory interneurons regulate temporal precision and correlations in cortical circuits. Trends Neurosci. 2018;41(10):689\u2013700.","journal-title":"Trends Neurosci"},{"issue":"12","key":"324_CR117","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1371\/journal.pbio.0030402","volume":"3","author":"MW Jones","year":"2005","unstructured":"Jones MW, Wilson MA. Theta rhythms coordinate hippocampal-prefrontal interactions in a spatial memory task. PLoS Biol. 2005;3(12):e402.","journal-title":"PLoS Biol"},{"issue":"23","key":"324_CR118","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1523\/JNEUROSCI.6162-08.2009","volume":"29","author":"EO Mann","year":"2009","unstructured":"Mann EO, Kohl MM, Paulsen O. Distinct roles of GABA(a) and GABA(B) receptors in balancing and terminating persistent cortical activity. J Neurosci. 2009;29(23):7513\u20138.","journal-title":"J Neurosci"},{"key":"324_CR119","doi-asserted-by":"publisher","first-page":"8927841","DOI":"10.1155\/2012\/892784","volume":"2012","author":"K Lehmann","year":"2012","unstructured":"Lehmann K, Steinecke A, Bolz J. GABA through the ages: regulation of cortical function and plasticity by inhibitory interneurons. Neural Plast. 2012;2012:8927841.","journal-title":"Neural Plast"},{"issue":"1","key":"324_CR120","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00001756-200401190-00003","volume":"15","author":"J-H Hu","year":"2004","unstructured":"Hu J-H, Ma Y-H, Jiang J, Yang N, Duan S, Jiang Z-H, et al. Cognitive impairment in mice over-expressing gamma-aminobutyric acid transporter 1 (GAT1). Neuroreport. 2004;15(1):9\u201312.","journal-title":"Neuroreport."},{"issue":"5","key":"324_CR121","first-page":"478","volume":"9","author":"L Prut","year":"2010","unstructured":"Prut L, Prenosil G, Willadt S, Vogt K, Fritschy J-M, Crestani F. A reduction in hippocampal GABA a receptor \u03b15 subunits disrupts the memory for location of objects in mice. Genes. Brain Behav. 2010;9(5):478\u201388.","journal-title":"Brain Behav"},{"issue":"7","key":"324_CR122","doi-asserted-by":"publisher","first-page":"e40555","DOI":"10.1371\/journal.pone.0040555","volume":"7","author":"Y Andrews-Zwilling","year":"2012","unstructured":"Andrews-Zwilling Y, Gillespie AK, Kravitz AV, Nelson AB, Devidze N, Lo I, et al. Hilar GABAergic interneuron activity controls spatial learning and memory retrieval. PLoS One. 2012;7(7):e40555.","journal-title":"PLoS One"},{"issue":"2","key":"324_CR123","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2353\/ajpath.2010.090973","volume":"177","author":"M Buttini","year":"2010","unstructured":"Buttini M, Masliah E, Yu G-Q, Palop JJ, Chang S, Bernardo A, et al. Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. Am J Pathol. 2010;177(2):563\u20139.","journal-title":"Am J Pathol"},{"issue":"3","key":"324_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0059478","volume":"8","author":"S Jain","year":"2013","unstructured":"Jain S, Yoon SY, Leung L, Knoferle J, Huang Y. Cellular source-specific effects of apolipoprotein (Apo) E4 on dendrite Arborization and dendritic spine development. PLoS One. 2013;8(3):1\u201314.","journal-title":"PLoS One"},{"issue":"42","key":"324_CR125","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1523\/JNEUROSCI.2281-14.2014","volume":"34","author":"J Knoferle","year":"2014","unstructured":"Knoferle J, Yoon SY, Walker D, Leung L, Gillespie AK, Tong LM, et al. Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice. J Neurosci. 2014 Oct 15;34(42):14069\u201378.","journal-title":"J Neurosci"},{"issue":"7","key":"324_CR126","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1523\/JNEUROSCI.3815-15.2016","volume":"36","author":"LM Tong","year":"2016","unstructured":"Tong LM, Yoon SY, Andrews-Zwilling Y, Yang A, Lin V, Lei H, et al. Enhancing GABA signaling during middle adulthood prevents age-dependent GABAergic interneuron decline and learning and memory deficits in ApoE4 mice. J Neurosci. 2016;36(7):2316\u201322.","journal-title":"J Neurosci"},{"issue":"29","key":"324_CR127","doi-asserted-by":"publisher","first-page":"9506","DOI":"10.1523\/JNEUROSCI.0693-14.2014","volume":"34","author":"LM Tong","year":"2014","unstructured":"Tong LM, Djukic B, Arnold C, Gillespie AK, Yoon SY, Wang MM, et al. Inhibitory interneuron progenitor transplantation restores Normal learning and memory in ApoE4 Knock-in mice without or with A\u03b2 accumulation. J Neurosci. 2014;34(29):9506\u201315.","journal-title":"J Neurosci"},{"issue":"5","key":"324_CR128","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, Najm R, Xu Q, Jeong D, Walker D, Balestra ME, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a Small-molecule structure corrector. Nat Med. 2018;24(5):647\u201357.","journal-title":"Nat Med"},{"issue":"6","key":"324_CR129","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.neuron.2018.06.011","volume":"98","author":"Y-T Lin","year":"2018","unstructured":"Lin Y-T, Seo J, Gao F, Feldman HM, Wen H-L, Penney J, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98(6):1294.","journal-title":"Neuron."},{"key":"324_CR130","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fncir.2014.00003","volume":"8","author":"V Lee","year":"2014","unstructured":"Lee V, Maguire J. The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type. Front Neural Circuits. 2014;8:3.","journal-title":"Front Neural Circuits"},{"key":"324_CR131","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainresbull.2017.11.016","volume":"141","author":"EK Lucas","year":"2018","unstructured":"Lucas EK, Clem RL. GABAergic interneurons: the orchestra or the conductor in fear learning and memory? Brain Res Bull. 2018;141:13\u20139.","journal-title":"Brain Res Bull"},{"issue":"2\u20133","key":"324_CR132","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.eplepsyres.2010.07.020","volume":"91","author":"Y Fu","year":"2010","unstructured":"Fu Y, Lv R, Jin L, Lu Q, Shao X, He J, et al. Association of apolipoprotein E polymorphisms with temporal lobe epilepsy in a Chinese Han population. Epilepsy Res. 2010;91(2\u20133):253\u20139.","journal-title":"Epilepsy Res"},{"issue":"9","key":"324_CR133","doi-asserted-by":"publisher","first-page":"e2894","DOI":"10.1097\/MD.0000000000002894","volume":"95","author":"Z Li","year":"2016","unstructured":"Li Z, Ding C, Gong X, Wang X, Cui T. Apolipoprotein E \u03b54 allele was associated with Nonlesional mesial temporal lobe epilepsy in Han Chinese population. Medicine (Baltimore). 2016;95(9):e2894.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"324_CR134","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/archneur.60.6.818","volume":"60","author":"Ramon Diaz-Arrastia","year":"2003","unstructured":"Diaz-Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, et al. Increased risk of late posttraumatic seizures associated with inheritance of APOE \u22084 allele. Arch Neurol. 2003;60(6):818\u201322.","journal-title":"Archives of Neurology"},{"issue":"6","key":"324_CR135","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10072-008-1060-9","volume":"29","author":"A Salzmann","year":"2008","unstructured":"Salzmann A, Perroud N, Crespel A, Lambercy C, Malafosse A. Candidate genes for temporal lobe epilepsy: a replication study. Neurol Sci. 2008;29(6):397\u2013403.","journal-title":"Neurol Sci"},{"issue":"11","key":"324_CR136","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2018.1935","volume":"75","author":"EL Johnson","year":"2018","unstructured":"Johnson EL, Krauss GL, Lee AK, Schneider ALC, Dearborn JL, Kucharska-Newton AM, et al. Association between midlife risk factors and late-onset epilepsy: results from the atherosclerosis risk in communities study. JAMA Neurol. 2018;75(11):1375\u201382.","journal-title":"JAMA Neurol."},{"issue":"3","key":"324_CR137","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/WNL.55.3.435","volume":"55","author":"RS Briellmann","year":"2000","unstructured":"Briellmann RS, Torn-Broers Y, Busuttil BE, Major BJ, Kalnins RM, Olsen M, et al. APOE \u03b54 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology. 2000;55(3):435\u20137.","journal-title":"Neurology."},{"issue":"3","key":"324_CR138","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eplepsyres.2010.05.007","volume":"90","author":"MA Kauffman","year":"2010","unstructured":"Kauffman MA, Consalvo D, Moron DG, Lereis VP, Kochen S. ApoE \u025b4 genotype and the age at onset of temporal lobe epilepsy: a case\u2013control study and meta-analysis. Epilepsy Res. 2010;90(3):234\u20139.","journal-title":"Epilepsy Res"},{"issue":"9","key":"324_CR139","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1080\/00207454.2016.1264396","volume":"127","author":"B Leal","year":"2017","unstructured":"Leal B, Chaves J, Carvalho C, Bettencourt A, Freitas J, Lopes J, et al. Age of onset of mesial temporal lobe epilepsy with hippocampal sclerosis: the effect of apolipoprotein E and febrile seizures. Int J Neurosci. 2017;127(9):800\u20134.","journal-title":"Int J Neurosci"},{"key":"324_CR140","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1741-7015-10-35","volume":"10","author":"O Aboud","year":"2012","unstructured":"Aboud O, Mrak RE, Boop F, Griffin ST. Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience. BMC Med. 2012;10:35.","journal-title":"BMC Med"},{"issue":"3","key":"324_CR141","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1582-4934.2005.tb00500.x","volume":"9","author":"D Sporis","year":"2005","unstructured":"Sporis D, Sertic J, Henigsberg N, Mahovic D, Bogdanovic N, Babic T. Association of refractory complex partial seizures with a polymorphism of ApoE genotype. J Cell Mol Med. 2005;9(3):698\u2013703.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"324_CR142","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1532-5415.2008.01826.x","volume":"56","author":"Carla R. Schubert","year":"2008","unstructured":"Schubert CR, Carmichael LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological sotudy of older adults. J Am Geriatr Soc. 2008;56(8):1517\u201321.","journal-title":"Journal of the American Geriatrics Society"},{"issue":"10","key":"324_CR143","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.biopsych.2008.06.020","volume":"64","author":"DP Devanand","year":"2008","unstructured":"Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer\u2019s disease. Biol Psychiatry. 2008;64(10):871\u20139.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"324_CR144","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10519-009-9289-5","volume":"39","author":"JK Olofsson","year":"2009","unstructured":"Olofsson JK, R\u00f6nnlund M, Nordin S, Nyberg L, Nilsson L-G, Larsson M. Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-\u03b54. Behav Genet. 2009;39(5):496\u2013503.","journal-title":"Behav Genet"},{"key":"324_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropsychologia.2016.03.004","volume":"85","author":"JK Olofsson","year":"2016","unstructured":"Olofsson JK, Josefsson M, Ekstr\u00f6m I, Wilson D, Nyberg L, Nordin S, et al. Long-term episodic memory decline is associated with olfactory deficits only in carriers of ApoE-\u04544. Neuropsychologia. 2016;85:1\u20139.","journal-title":"Neuropsychologia."},{"issue":"4","key":"324_CR146","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4172\/2471-2701.1000169","volume":"3","author":"MM Misiak","year":"2017","unstructured":"Misiak MM, Hipolito MS, Ressom HW, Obisesan TO, Manaye KF, Nwulia EA. Apo E4 alleles and impaired olfaction as predictors of Alzheimer\u2019s disease. Clin Exp Psychol. 2017;3(4):169.","journal-title":"Clin Exp Psychol"},{"key":"324_CR147","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neurobiolaging.2016.12.005","volume":"51","author":"B Hu","year":"2017","unstructured":"Hu B, Geng C, Hou X-Y. Oligomeric amyloid-\u03b2 peptide disrupts olfactory information output by impairment of local inhibitory circuits in rat olfactory bulb. Neurobiol Aging. 2017;51:113\u201321.","journal-title":"Neurobiol Aging"},{"key":"324_CR148","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuroscience.2016.12.004","volume":"343","author":"KY Peng","year":"2017","unstructured":"Peng KY, Mathews PM, Levy E, Wilson DA. Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments. Neuroscience. 2017;343:364\u201371.","journal-title":"Neuroscience."},{"issue":"31","key":"324_CR149","first-page":"1","volume":"3","author":"IR Holtman","year":"2015","unstructured":"Holtman IR, Raj DD, Miller JA, Schaafsma W, Yin Z, Brouwer N, et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions : a co-expression meta-analysis. Acta Neuropathol. 2015;3(31):1\u201318.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"324_CR150","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"CS Frigerio","year":"2019","unstructured":"Frigerio CS, Wolfs L, Fattorelli N, Perry VH, Fiers M, De SB, et al. The Major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 2019;27(4):1293\u2013306.","journal-title":"Cell Rep"},{"issue":"3","key":"324_CR151","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566\u201381 e9.","journal-title":"Immunity."},{"issue":"9","key":"324_CR152","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer\u2019s disease. J Clin Invest. 2017;127(9):3240\u20139.","journal-title":"J Clin Invest"},{"issue":"2","key":"324_CR153","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2017","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2017;217(2):459\u201372.","journal-title":"J Cell Biol"},{"key":"324_CR154","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1038\/ncomms5486","volume":"5","author":"Z Chen","year":"2014","unstructured":"Chen Z, Jalabi W, Hu W, Park H, Gale JT, Kidd GJ, et al. Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain. Nat Commun. 2014;5:4486.","journal-title":"Nat Commun"},{"issue":"10","key":"324_CR155","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/epi.12354","volume":"5","author":"C Roseti","year":"2013","unstructured":"Roseti C, Fucile S, Lauro C, Martinello K, Bertollini C, Esposito V, et al. Fractalkine\/CX3CL1 modulates GABA(a) currents in human temporal lobe epilepsy. Epilepsia. 2013;5(10):1834\u201344.","journal-title":"Epilepsia."},{"issue":"3","key":"324_CR156","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/glia.440080306","volume":"8","author":"G Brockner","year":"1993","unstructured":"Brockner G, Brauer K, Hartg W, Wolff JR, Rickma MJ, Derouiche A, et al. Perineuronal nets provide a Polyanionic , glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia. 1993;8(3):183\u2013200.","journal-title":"Glia."},{"issue":"11","key":"324_CR157","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/dneu.20974","volume":"7","author":"JCF Kwok","year":"2011","unstructured":"Kwok JCF, Dick G, Wang D, Fawcett JW. Extracellular matrix and Perineuronal nets in CNS repair. Dev Neurobiol. 2011;7(11):1073\u201389.","journal-title":"Dev Neurobiol"},{"issue":"4","key":"324_CR158","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-005-1060-2","volume":"110","author":"S Baig","year":"2005","unstructured":"Baig S, Wilcock GK, Love S. Loss of perineuronal net N -acetylgalactosamine in Alzheimer\u2019s disease. Acta Neuropathol. 2005;110(4):393\u2013401.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"324_CR159","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/00001756-199210000-00012","volume":"3","author":"W H\u00e4rtig","year":"1992","unstructured":"H\u00e4rtig W, Brauer K. G B. Wisteria floribunda agglutinin-labelled nets surround parvalbumin- containing neurons. Neuroreport. 1992;3(10):869\u201372.","journal-title":"Neuroreport."},{"key":"324_CR160","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2018.08.024","volume":"72","author":"V Cattaud","year":"2018","unstructured":"Cattaud V, Bezzina C, Rey CC, Lejards C, Dahan L, Verret L. Early disruption of parvalbumin expression and perineuronal nets in the hippocampus of the Tg2576 mouse model of Alzheimer\u2019s disease can be rescued by enriched environment. Neurobiol Aging. 2018;72:147\u201358.","journal-title":"Neurobiol Aging"},{"issue":"22","key":"324_CR161","doi-asserted-by":"publisher","first-page":"9130","DOI":"10.1073\/pnas.1300454110","volume":"110","author":"J Cabungcal","year":"2013","unstructured":"Cabungcal J, Steullet P, Morishita H, Kraftsik R, Cuenod M, Hensch TK. Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci. 2013;110(22):9130\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"324_CR162","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.neuropsychologia.2008.01.026","volume":"46","author":"J Persson","year":"2008","unstructured":"Persson J, Lind J, Larsson A, Ingvar M, Sleegers K, Van Broeckhoven C, et al. Altered deactivation in individuals with genetic risk for Alzheimer\u2019s disease. Neuropsychologia. 2008;46(6):1679\u201387.","journal-title":"Neuropsychologia."},{"issue":"4","key":"324_CR163","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.neuroimage.2009.06.021","volume":"47","author":"AS Fleisher","year":"2009","unstructured":"Fleisher AS, Sherzai A, Taylor C, Langbaum JBS, Chen K, Buxton RB. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer\u2019s disease risk groups. Neuroimage. 2009;47(4):1678\u201390.","journal-title":"Neuroimage."},{"issue":"1","key":"324_CR164","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1155\/2009\/276384","volume":"21","author":"M Pihlajam\u00e4ki","year":"2009","unstructured":"Pihlajam\u00e4ki M, Sperling RA. Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer\u2019s disease and at-risk older individuals. Behav Neurol. 2009;21(1):77\u201391.","journal-title":"Behav Neurol"},{"issue":"47","key":"324_CR165","doi-asserted-by":"publisher","first-page":"18566","DOI":"10.1523\/JNEUROSCI.1973-13.2013","volume":"33","author":"Y Hu","year":"2013","unstructured":"Hu Y, Chen X, Gu H, Yang Y. Resting-state glutamate and GABA concentrations predict task-induced deactivation in the default mode network. J Neurosci. 2013;33(47):18566\u201373.","journal-title":"J Neurosci"},{"key":"324_CR166","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroimage.2012.09.029","volume":"64","author":"D Kapogiannis","year":"2013","unstructured":"Kapogiannis D, Reiter DA, Willette AA, Mattson MP. Posteromedial cortex glutamate and GABA predict intrinsic functional connectivity of the default mode network. Neuroimage. 2013;64:112\u20139.","journal-title":"Neuroimage."},{"issue":"4","key":"324_CR167","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/cercor\/bhy059","volume":"29","author":"Xi Chen","year":"2018","unstructured":"Chen X, Fan X, Hu Y, Zuo C, Whitfield-Gabrieli S, Holt D, et al. Regional GABA concentrations modulate inter-network resting-state functional connectivity. Cereb Cortex. 2018. https:\/\/doi.org\/10.1093\/cercor\/bhy059 .","journal-title":"Cerebral Cortex"},{"key":"324_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1440.011","volume":"1124","author":"RL Buckner","year":"2008","unstructured":"Buckner RL, Andrews-Hanna JR, Schacter DL. The Brain\u2019s default network:anatomy, function and relevance to disease. Ann N Y Acad Sci. 2008;1124:1\u201338.","journal-title":"Ann N Y Acad Sci"},{"key":"324_CR169","doi-asserted-by":"crossref","first-page":"535816","DOI":"10.4061\/2011\/535816","volume":"2011","author":"K Mevel","year":"2011","unstructured":"Mevel K, Ch\u00e9telat G, Eustache F, Desgranges B. The default mode network in healthy aging and Alzheimer\u2019s disease. Int J Alzheimers Dis. 2011;2011:535816.","journal-title":"Int J Alzheimers Dis"},{"issue":"24","key":"324_CR170","doi-asserted-by":"publisher","first-page":"14504","DOI":"10.1073\/pnas.2235925100","volume":"100","author":"C Lustig","year":"2003","unstructured":"Lustig C, Snyder AZ, Bhakta M, O\u2019Brien KC, McAvoy M, Raichle ME, et al. Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci U S A. 2003;100(24):14504\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"324_CR171","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neubiorev.2008.09.002","volume":"33","author":"SJ Broyd","year":"2009","unstructured":"Broyd SJ, Demanuele C, Debener S, Helps SK, James CJ, Sonuga-Barke EJS. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev. 2009;33(3):279\u201396.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"324_CR172","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/01.wnl.0000171450.97464.49","volume":"65","author":"BC Dickerson","year":"2005","unstructured":"Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005;65(3):404\u201311.","journal-title":"Neurology."},{"issue":"3","key":"324_CR173","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1212\/01.WNL.0000150885.00929.7E","volume":"64","author":"MW Bondi","year":"2005","unstructured":"Bondi MW, Houston WS, Eyler LT, Brown GG. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology. 2005;64(3):501\u20138.","journal-title":"Neurology."},{"issue":"1","key":"324_CR174","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s41467-017-01444-0","volume":"8","author":"T Nuriel","year":"2017","unstructured":"Nuriel T, Angulo SL, Khan U, Ashok A, Chen Q, Figueroa HY, et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology. Nat Commun. 2017;8(1):1464.","journal-title":"Nat Commun"},{"key":"324_CR175","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.nicl.2015.02.009","volume":"7","author":"A Bakker","year":"2015","unstructured":"Bakker A, Albert MS, Krauss G, Speck CL, Gallagher M. Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance. NeuroImage Clin. 2015;7:688\u201398.","journal-title":"NeuroImage Clin"},{"issue":"9","key":"324_CR176","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hipo.20808","volume":"21","author":"MA Yassa","year":"2011","unstructured":"Yassa MA, Lacy JW, Stark SM, Albert MS, Gallagher M, Stark CE. Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults. Hippocampus. 2011;21(9):968\u201379.","journal-title":"Hippocampus."},{"issue":"6","key":"324_CR177","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/jnnp.2007.124149","volume":"79","author":"SL Miller","year":"2008","unstructured":"Miller SL, Fenstermacher E, Bates J, Blacker D, Sperling RA, Dickerson BC. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J Neurol Neurosurg Psychiatry. 2008;79(6):630\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"324_CR178","doi-asserted-by":"publisher","first-page":"e22978","DOI":"10.7554\/eLife.22978","volume":"6","author":"SL Leal","year":"2017","unstructured":"Leal SL, Landau SM, Bell RK, Jagust WJ. Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. Elife. 2017;6:e22978.","journal-title":"Elife."},{"issue":"17","key":"324_CR179","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1073\/pnas.0811879106","volume":"106","author":"N Filippini","year":"2009","unstructured":"Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, et al. Distinct patterns of brain activity in young carriers of the APOE-\u03b54 allele. Proc Natl Acad Sci U S A. 2009;106(17):7209\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"324_CR180","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM200008173430701","volume":"343","author":"SY Bookheimer","year":"2000","unstructured":"Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer\u2019s disease. N Engl J Med. 2000;343(7):450\u20136.","journal-title":"N Engl J Med"},{"issue":"4","key":"324_CR181","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jalz.2009.07.003","volume":"6","author":"NA Dennis","year":"2010","unstructured":"Dennis NA, Browndyke JN, Stokes J, Need A, Burke JR, Welsh-Bohmer KA, et al. Temporal lobe functional activity and connectivity in young adult APOE \u025b4 carriers. Alzheimers Dement. 2010;6(4):303\u201311.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"324_CR182","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2016.04.009","volume":"90","author":"AK Gillespie","year":"2016","unstructured":"Gillespie AK, Jones EA, Lin Y-H, Karlsson MP, Kay K, Yoon SY, et al. Apolipoprotein E4 causes age-dependent disruption of slow gamma oscillations during hippocampal sharp-wave ripples. Neuron. 2016;90(4):740\u201351.","journal-title":"Neuron."},{"issue":"10","key":"324_CR183","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/hipo.22488","volume":"25","author":"G Buzs\u00e1ki","year":"2015","unstructured":"Buzs\u00e1ki G. Hippocampal sharp wave-ripple: a cognitive biomarker for episodic memory and planning. Hippocampus. 2015;25(10):1073\u2013188.","journal-title":"Hippocampus."},{"issue":"4","key":"324_CR184","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.neuron.2012.06.014","volume":"75","author":"MF Carr","year":"2012","unstructured":"Carr MF, Karlsson MP, Frank LM. Transient slow gamma synchrony underlies hippocampal memory replay. Neuron. 2012;75(4):700\u201313.","journal-title":"Neuron."},{"key":"324_CR185","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/B978-0-12-394816-8.00003-9","volume":"64","author":"DF Silva","year":"2012","unstructured":"Silva DF, Selfridge JE, Lu J, E L, Cardoso SM, Swerdlow RH. Mitochondrial abnormalities in Alzheimer\u2019s disease. Possible targets for therapeutic intervention. Adv Pharmacol. 2012;64:83\u2013126.","journal-title":"Adv Pharmacol"},{"issue":"8","key":"324_CR186","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","volume":"1842","author":"RH Swerdlow","year":"2014","unstructured":"Swerdlow RH, Burns JM, Khan SM. The Alzheimer\u2019s disease mitochondrial cascade hypothesis: Progress and perspectives. Biochim Biophys Acta. 2014;1842(8):1219\u201331.","journal-title":"Biochim Biophys Acta"},{"issue":"51","key":"324_CR187","doi-asserted-by":"publisher","first-page":"18694","DOI":"10.1073\/pnas.0508254102","volume":"102","author":"S Chang","year":"2005","unstructured":"Chang S, ran Ma T, Miranda RD, Balestra ME, Mahley RW, Huang Y. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A. 2005;102(51):18694\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"324_CR188","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","volume":"286","author":"HK Chen","year":"2011","unstructured":"Chen HK, Ji ZS, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ, et al. Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J Biol Chem. 2011;286(7):5215\u201321.","journal-title":"J Biol Chem"},{"issue":"8","key":"324_CR189","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/jcbfm.2014.104","volume":"34","author":"O Kann","year":"2014","unstructured":"Kann O, Papageorgiou IE, Draguhn A. Highly energized inhibitory interneurons are a central element for information processing in cortical networks. J Cereb Blood Flow Metab. 2014;34(8):1270\u201382.","journal-title":"J Cereb Blood Flow Metab"},{"key":"324_CR190","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nbd.2015.08.005","volume":"90","author":"O Kann","year":"2016","unstructured":"Kann O. The interneuron energy hypothesis: implications for brain disease. Neurobiol Dis. 2016;90:75\u201385.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"324_CR191","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3233\/JAD-181184","volume":"68","author":"AL Orr","year":"2019","unstructured":"Orr AL, Kim C, Jimenez-morales D, Newton BW, Johnson J, Swaney D, et al. Neuronal apolipoprotein E4 expression results in proteome-wide alterations and compromises bioenergetic capacity by disrupting mitochondrial function. J Alzheimers Dis. 2019;68(3):991\u20131011.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"324_CR192","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","volume":"12","author":"T Kondo","year":"2013","unstructured":"Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, et al. Modeling Alzheimer\u2019s disease with iPSCs reveals stress phenotypes associated with intracellular A\u03b2 and differential drug responsiveness. Cell Stem Cell. 2013;12(4):487\u201396.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"324_CR193","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.celrep.2017.10.109","volume":"21","author":"T Kondo","year":"2017","unstructured":"Kondo T, Imamura K, Funayama M, Tsukita K, Miyake M, Ohta A, et al. iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid \u03b2 combination for Alzheimer\u2019s disease. Cell Rep. 2017;21(8):2304\u201312.","journal-title":"Cell Rep"},{"key":"324_CR194","first-page":"31","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, Sun H, Chen Z, Xu H, Bu G, Zheng H. Implications of GABAergic neurotransmission in Alzheimer\u2019s disease. Front Aging Neurosci. 2016;8:31.","journal-title":"Front Aging Neurosci"},{"key":"324_CR195","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fncel.2014.00167","volume":"8","author":"MO Nava-Mesa","year":"2014","unstructured":"Nava-Mesa MO, Jim\u00e9nez-D\u00ed\u00adaz L, Yajeya J, Navarro-Lopez JD. GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer\u2019s disease. Front Cell Neurosci. 2014;8:167.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"324_CR196","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/jnc.14345","volume":"146","author":"B Calvo-Flores Guzm\u00e1n","year":"2018","unstructured":"Calvo-Flores Guzm\u00e1n B, Vinnakota C, Govindpani K, Waldvogel HJ, Faull RLM, Kwakowsky A. The GABAergic system as a therapeutic target for Alzheimer\u2019s disease. J Neurochem. 2018;146(6):649\u201369.","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"324_CR197","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yebeh.2010.02.011","volume":"18","author":"C Helmstaedter","year":"2010","unstructured":"Helmstaedter C, Witt J-A. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial. Epilepsy Behav. 2010;18(1\u20132):74\u201380.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"324_CR198","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1533317508325095","volume":"25","author":"CF Lippa","year":"2010","unstructured":"Lippa CF, Rosso A, Hepler M, Jenssen S, Pillai J, Irwin D. Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment. Am J Alzheimer\u2019s Dis Other Dementiasr. 2010;25(2):149\u201354.","journal-title":"Am J Alzheimer\u2019s Dis Other Dementiasr"},{"key":"324_CR199","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neurobiolaging.2016.12.021","volume":"54","author":"Rebecca P. Haberman","year":"2017","unstructured":"Haberman RP, Koh MT, Gallagher M. Heightened cortical excitability in aged rodents with memory impairment. Neurobiol Aging. 2017;54:144\u201351.","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"324_CR200","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.brs.2015.04.005","volume":"8","author":"D Vidal-Pi\u00f1eiro","year":"2015","unstructured":"Vidal-Pi\u00f1eiro D, Mart\u00edn-Trias P, Falc\u00f3n C, Bargall\u00f3 N, Clemente IC, Valls-Sol\u00e9 J, et al. Neurochemical modulation in posteromedial default-mode network cortex induced by transcranial magnetic stimulation. Brain Stimul. 2015;8(5):937\u201344.","journal-title":"Brain Stimul"},{"issue":"7247","key":"324_CR201","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nature08002","volume":"459","author":"JA Cardin","year":"2009","unstructured":"Cardin JA, Carl\u00e9n M, Meletis K, Knoblich U, Zhang F, Deisseroth K, et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature. 2009;459(7247):663\u20137.","journal-title":"Nature."},{"issue":"7247","key":"324_CR202","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nature07991","volume":"459","author":"VS Sohal","year":"2009","unstructured":"Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459(7247):698\u2013702.","journal-title":"Nature."},{"issue":"33","key":"324_CR203","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.1523\/JNEUROSCI.0273-18.2018","volume":"38","author":"N Ketz","year":"2018","unstructured":"Ketz N, Jones AP, Bryant NB, Clark VP, Pilly PK. Closed-loop slow-wave tACS improves sleep-dependent long-term memory generalization by modulating endogenous oscillations. J Neurosci. 2018;38(33):7314\u201326.","journal-title":"J Neurosci"},{"issue":"7632","key":"324_CR204","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature20587","volume":"540","author":"HF Iaccarino","year":"2016","unstructured":"Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230\u20135.","journal-title":"Nature."},{"issue":"2","key":"324_CR205","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cell.2019.02.014","volume":"177","author":"AJ Martorell","year":"2019","unstructured":"Martorell AJ, Paulson AL, Suk H, Boyden ES, Singer AC, Tsai L. Multi-sensory gamma stimulation ameliorates Alzheimer\u2019s-associated pathology and improves cognition. Cell. 2019;177(2):256\u201371 e22.","journal-title":"Cell."},{"issue":"2","key":"324_CR206","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nn.3006","volume":"15","author":"K-X Li","year":"2011","unstructured":"Li K-X, Lu Y-M, Xu Z-H, Zhang J, Zhu J-M, Zhang J-M, et al. Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat Neurosci. 2011;15(2):267\u201373.","journal-title":"Nat Neurosci"},{"issue":"10","key":"324_CR207","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41593-018-0225-y","volume":"21","author":"T Marissal","year":"2018","unstructured":"Marissal T, Salazar RF, Bertollini C, Mutel S, De Roo M, Rodriguez I, et al. Restoring wild-type-like CA1 network dynamics and behavior during adulthood in a mouse model of schizophrenia. Nat Neurosci. 2018;21(10):1412\u201320.","journal-title":"Nat Neurosci"},{"issue":"6","key":"324_CR208","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.cell.2016.08.055","volume":"166","author":"D Srivastava","year":"2016","unstructured":"Srivastava D, DeWitt N. In vivo cellular reprogramming: the next generation. Cell. 2016;166(6):1386\u201396.","journal-title":"Cell."},{"issue":"3","key":"324_CR209","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.tins.2014.01.003","volume":"37","author":"JA Tyson","year":"2014","unstructured":"Tyson JA, Anderson SA. GABAergic interneuron transplants to study development and treat disease. Trends Neurosci. 2014;37(3):169\u201377.","journal-title":"Trends Neurosci"},{"issue":"1","key":"324_CR210","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuron.2015.03.002","volume":"86","author":"JA Steinbeck","year":"2015","unstructured":"Steinbeck JA, Studer L. Moving stem cells to the clinic: potential and limitations for brain repair. Neuron. 2015;86(1):187\u2013206.","journal-title":"Neuron."},{"key":"324_CR211","first-page":"282","volume":"8","author":"X Li","year":"2016","unstructured":"Li X, Zhu H, Sun X, Zuo F, Lei J, Wang Z, et al. Human neural stem cell transplantation rescues cognitive defects in APP\/PS1 model of Alzheimer\u2019s disease by enhancing neuronal connectivity and metabolic activity. Front Aging Neurosci. 2016;8:282.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"324_CR212","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.stem.2014.10.006","volume":"15","author":"M Cunningham","year":"2014","unstructured":"Cunningham M, Cho J-H, Leung A, Savvidis G, Ahn S, Moon M, et al. hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice. Cell Stem Cell. 2014;15(5):559\u201373.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"324_CR213","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2018.02.029","volume":"98","author":"M Martinez-Losa","year":"2018","unstructured":"Martinez-Losa M, Tracy TE, Ma K, Verret L, Clemente-Perez A, Khan AS, et al. Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer\u2019s disease. Neuron. 2018;98(1):75\u201389.e5.","journal-title":"Neuron."}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-019-0324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-019-0324-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-019-0324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T10:44:16Z","timestamp":1721385856000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-019-0324-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":213,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1186\/s13024-019-0324-6","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YH is a co-founder and SAB member of E-scape Bio, Inc. and GABAeron, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}